And that's why people like Lawrence Gostin are rethinking what public health authorities should do about people with suspected XDR-TB in the weeks before the diagnosis is in.
XDR-TB is a particularly dangerous form of the disease that is resistant not only to the two most potent TB drugs, but also a handful of second-line drugs.
For confirmed XDR-TB, in which the bacterium is resistant to the most potent first- and second-line TB medicines, the WHO recommends that a proper combination of any medicine left among those available, dictated by knowledge of susceptibility, should be used.